EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deficiency of 2‐Oxoglutarate Carrier (Slc25a11) Drives RPE Epithelial‐to‐Mesenchymal Transition and Exacerbates Subretinal Fibrosis in Neovascular Age‐Related Macular Degeneration

Mo Wang iD, Feng-Juan Gao iD, Wenyi Tang, Boya Lei iD, Fangyuan Hu, Jun Ma, Srinivas R Sadda, Ram Kannan, Parameswaran G Sreekumar, Gezhi Xu iD

Aging Cell · 2025

DOI: 10.1111/acel.70271 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Cell, 2025. Verfasst von Mo Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Eye Diseases Prevention &Treatment Center/Shanghai Eye Hospital, School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Retinal Pigment Epithelium, Macular Degeneration. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, Keck Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Subretinal fibrosis significantly contributes to vision loss in neovascular age‐related macular degeneration (nAMD). Epithelial‐to‐mesenchymal transition (EMT) in RPE cells is a key early step in subretinal fibrosis. While mitochondrial dysfunction in RPE is involved, the metabolic and molecular connections between EMT and mitochondria are not well understood. This study explores the role of oxoglutarate carrier (OGC; Slc25a11) on EMT and investigates the molecular mechanisms, focusing on its role in mitochondrial metabolism and GSH transport. OGC‐silenced or overexpressed ARPE‐19 cells were treated with TGF‐β2 (10 ng/mL) for 48 h. EMT markers, cell migration, mtGSH, and mitochondrial bioenergetics and signaling pathways were assessed. In vivo, subretinal fibrosis was induced in wild‐type and OGC +/− mice via laser photocoagulation. Fibrosis volume was measured using optical coherence tomography and immunostaining in RPE‐choroid flat mounts. OGC silencing aggravated EMT, while overexpression attenuated TGF‐β2‐induced EMT, cell proliferation, and migration. OGC knockdown significantly enhanced RPE EMT, as evidenced by upregulated expression of α‐SMA, fibronectin, collagen type I, and Slug, while E‐cadherin was downregulated. OGC overexpression improved mitochondrial bioenergetics, whereas its inhibition reduced mitochondrial respiration, which was further aggravated by co‐treatment with TGF‐β2. Loss of OGC promoted cell proliferation and migration through Slug‐mediated EMT. OGC depletion stimulated EMT via pSmad2/3 upregulation, dependent on the PI3K/AKT signaling pathway activation. In vivo studies further demonstrate that subretinal fibrosis was significantly augmented in OGC +/− mice via TGF‐β2‐dependent PI3K signaling. In conclusion, modulating OGC expression in RPE affects EMT and mitochondrial function, making OGC a potential therapeutic target for subretinal fibrosis in nAMD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionRetinal Pigment EpitheliumMacular DegenerationAnimalsMiceFibrosisHumansSignal TransductionMitochondriaMice, Inbred C57BL

Stichwörter der Autor:innen

OGCRPE‐EMTmitochondrial dysfunctionneovascular AMDsubretinal fibrosis

Autor:innen und Institutionen

  • Shanghai Eye Diseases Prevention &Treatment Center/Shanghai Eye Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Eye Institute, Eye and ENT Hospital, College of Medicine, Fudan University, Shanghai, China.
  • Shanghai Key Laboratory of Visual Impairment and Restoration, Science and Technology Commission of Shanghai Municipality, Shanghai, China.
  • Jules Stein Eye Institute, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA.
  • Department of Ophthalmology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California, USA.
  • Doheny Eye Institute, Pasadena, California, USA.

ORCID-Profile: Mo Wang, Feng-Juan Gao, Boya Lei, Gezhi Xu

Förderung

  • NEI NIH HHS
  • Keck Foundation
  • National Natural Science Foundation of China
  • National Eye Institute
  • W. M. Keck Foundation

Zitieren

APA

Wang, M., Gao, F. J., Tang, W., Lei, B., Hu, F., Ma, J., Sadda, S. R., Kannan, R., Sreekumar, P. G., & Xu, G. (2025). Deficiency of 2‐Oxoglutarate Carrier (Slc25a11) Drives RPE Epithelial‐to‐Mesenchymal Transition and Exacerbates Subretinal Fibrosis in Neovascular Age‐Related Macular Degeneration. Aging Cell. https://doi.org/10.1111/acel.70271

Vancouver

Wang M, Gao FJ, Tang W, Lei B, Hu F, Ma J, et al. Deficiency of 2‐Oxoglutarate Carrier (Slc25a11) Drives RPE Epithelial‐to‐Mesenchymal Transition and Exacerbates Subretinal Fibrosis in Neovascular Age‐Related Macular Degeneration. Aging Cell. 2025. doi:10.1111/acel.70271

BibTeX
@article{Wang2025,
  author = {Wang, Mo and Gao, Feng-Juan and Tang, Wenyi and Lei, Boya and Hu, Fangyuan and Ma, Jun and Sadda, Srinivas R and Kannan, Ram and Sreekumar, Parameswaran G and Xu, Gezhi},
  title = {Deficiency of 2‐Oxoglutarate Carrier (Slc25a11) Drives RPE Epithelial‐to‐Mesenchymal Transition and Exacerbates Subretinal Fibrosis in Neovascular Age‐Related Macular Degeneration},
  journal = {Aging Cell},
  year = {2025},
  doi = {10.1111/acel.70271}
}
Kostenlos starten →